Revolution Medicines Inc (NASDAQ: RVMD) is 52.20% higher on its value in year-to-date trading and has touched a low of $15.44 and a high of $48.61 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RVMD stock was last observed hovering at around $42.85 in the last trading session, with the day’s gains setting it 0.8%.
Currently trading at $43.65, the stock is -1.58% and 3.69% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.82 million and changing 1.87% at the moment leaves the stock 31.59% off its SMA200. RVMD registered 49.03% gain for a year compared to 6-month gain of 47.92%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.40% loss in the last 1 month and extending the period to 3 months gives it a 10.76%, and is 1.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.96% over the week and 3.95% over the month.
Revolution Medicines Inc (RVMD) has around 378 employees, a market worth around $7.29B and $0.74M in sales. Profit margin for the company is -69973.99%. Distance from 52-week low is 182.71% and -10.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.58%).
The EPS is expected to grow by 10.44% this year.
Revolution Medicines Inc (RVMD) Top Institutional Holders
327.0 institutions hold shares in Revolution Medicines Inc (RVMD), with institutional investors hold 105.62% of the company’s shares. The shares outstanding are 164.67M, and float is at 138.72M with Short Float at 11.64%. Institutions hold 103.14% of the Float.
The top institutional shareholder in the company is VICTORY CAPITAL MANAGEMENT INC with over 0.6 million shares valued at $$19.36 million. The investor’s holdings represent 0.5308 of the RVMD Shares outstanding. As of 2024-03-31, the second largest holder is CITADEL ADVISORS LLC with 0.59 million shares valued at $$18.95 million to account for 0.5197 of the shares outstanding. The other top investors are BANK OF NEW YORK MELLON CORP which holds 0.53 million shares representing 0.4679 and valued at over $$17.06 million, while CITIGROUP INC holds 0.2454 of the shares totaling 0.28 million with a market value of $$8.95 million.
Revolution Medicines Inc (RVMD) Insider Activity
The most recent transaction is an insider sale by Kelsey Stephen Michael. SEC filings show that Kelsey Stephen Michael sold 16,667 shares of the company’s common stock on Aug 13 ’24 at a price of $42.98 per share for a total of $0.72 million. Following the sale, the insider now owns 0.27 million shares.
Still, SEC filings show that on Aug 01 ’24, GOLDSMITH MARK A () disposed off 10,000 shares at an average price of $45.88 for $0.46 million. The insider now directly holds 311,885 shares of Revolution Medicines Inc (RVMD).
